# A Survey on Efficacy and Safety in Patients With Endometriosis

> **NCT02921763** · — · COMPLETED · sponsor: **Mylan Inc.** · enrollment: 60 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Dydrogesterone

## Key facts

- **NCT ID:** NCT02921763
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-23
- **Primary completion:** 2017-09-21
- **Final completion:** 2017-10-13
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02921763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02921763, "A Survey on Efficacy and Safety in Patients With Endometriosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02921763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*